PATENT CLAIM ANALYSIS

Application Number: 16146762
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "451000"]

Abstract:
The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.

Claim (Index 149):
The method of  claim 147 , wherein the oral dosage form is a solid or semi-solid oral dosage form selected from a group of solid or semi-solid oral dosage forms consisting of a tablet, a capsule, a gel, a liquid dispersion, a pill, a powder, and a suspension.

Metadata:
- Claim Count in Document: 287.0
- Percentile: 97.0
- Lexical Diversity: 1.04
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15887523', '14788211', '14079548', '15671653', '14442711']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7611092310460449
- 35 USC 102 Novelty (BERT): 0.6759621120315165
- Combined Prediction Score: 0.7525945191445921
- Mean Citation Score: 425.65413
- Max Citation Score: 788.03906
- Similarity Product: 644.7477187959003

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test